{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T19:58:30Z","timestamp":1788897510523,"version":"build-2803163510"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,5,30]]},"DOI":"10.7759\/cureus.25508","type":"journal-article","created":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T05:46:05Z","timestamp":1653975965000},"source":"Crossref","is-referenced-by-count":2,"title":["Voriconazole Induced Cutaneous Squamous Cell Carcinoma in an Immunocompetent Patient"],"prefix":"10.7759","author":[{"given":"Kevin","family":"Parza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pratishtha","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Cvinar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terence","family":"Zimmerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Faris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00583-2015","article-title":"Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management","volume":"47","author":"Denning DW","year":"2016","unstructured":"Denning DW, Cadranel J, Beigelman-Aubry C, et al.. Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management. Eur Respir J. 2016, 47:45-68. 10.1183\/13993003.00583-2015","journal-title":"Eur Respir J"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0193732","article-title":"Twelve-month clinical outcomes of 206 patients with chronic pulmonary aspergillosis","volume":"13","author":"Bongomin F","year":"2018","unstructured":"Bongomin F, Harris C, Hayes G, Kosmidis C, Denning DW. Twelve-month clinical outcomes of 206 patients with chronic pulmonary aspergillosis. PLoS One. 2018, 13:e0193732. 10.1371\/journal.pone.0193732","journal-title":"PLoS One"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2010.03375.x","article-title":"Antifungal prophylaxis in lung transplantation - a world-wide survey","volume":"11","author":"Neoh CF","year":"2011","unstructured":"Neoh CF, Snell GI, Kotsimbos T, et al.. Antifungal prophylaxis in lung transplantation - a world-wide survey. Am J Transplant. 2011, 11:361-6. 10.1111\/j.1600-6143.2010.03375.x","journal-title":"Am J Transplant"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.14500","article-title":"Voriconazole and squamous cell carcinoma after lung transplantation: a multicenter study","volume":"18","author":"Hamandi B","year":"2018","unstructured":"Hamandi B, Fegbeutel C, Silveira FP, et al.. Voriconazole and squamous cell carcinoma after lung transplantation: a multicenter study. Am J Transplant. 2018, 18:113-24. 10.1111\/ajt.14500","journal-title":"Am J Transplant"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1H671","article-title":"Adverse effects of voriconazole: analysis of the French Pharmacovigilance Database","volume":"41","author":"Eiden C","year":"2007","unstructured":"Eiden C, Peyri\u00e8re H, Cociglio M, Djezzar S, Hansel S, Blayac JP, Hillaire-Buys D. Adverse effects of voriconazole: analysis of the French Pharmacovigilance Database. Ann Pharmacother. 2007, 41:755-63. 10.1345\/aph.1H671","journal-title":"Ann Pharmacother"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3121\/cmr.2008.806","article-title":"Voriconazole-induced photosensitivity","volume":"6","author":"Malani AN","year":"2008","unstructured":"Malani AN, Aronoff DM. Voriconazole-induced photosensitivity. Clin Med Res. 2008, 6:83-5. 10.3121\/cmr.2008.806","journal-title":"Clin Med Res"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1086\/511685","article-title":"Severe photosensitivity causing multifocal squamous cell carcinomas secondary to prolonged voriconazole therapy","volume":"44","author":"McCarthy KL","year":"2007","unstructured":"McCarthy KL, Playford EG, Looke DF, Whitby M. Severe photosensitivity causing multifocal squamous cell carcinomas secondary to prolonged voriconazole therapy. Clin Infect Dis. 2007, 44:55-6. 10.1086\/511685","journal-title":"Clin Infect Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit940","article-title":"Voriconazole-associated cutaneous malignancy: a literature review on photocarcinogenesis in organ transplant recipients","volume":"58","author":"Williams K","year":"2014","unstructured":"Williams K, Mansh M, Chin-Hong P, Singer J, Arron ST. Voriconazole-associated cutaneous malignancy: a literature review on photocarcinogenesis in organ transplant recipients. Clin Infect Dis. 2014, 58:997-1002. 10.1093\/cid\/cit940","journal-title":"Clin Infect Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.13431","article-title":"Voriconazole exposure and risk of cutaneous squamous cell carcinoma, aspergillus colonization, invasive aspergillosis and death in lung transplant recipients","volume":"16","author":"Mansh M","year":"2016","unstructured":"Mansh M, Binstock M, Williams K, et al.. Voriconazole exposure and risk of cutaneous squamous cell carcinoma, aspergillus colonization, invasive aspergillosis and death in lung transplant recipients. Am J Transplant. 2016, 16:262-70. 10.1111\/ajt.13431","journal-title":"Am J Transplant"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2014.10.023","article-title":"Voriconazole phototoxicity in children: a retrospective review","volume":"72","author":"Sheu J","year":"2015","unstructured":"Sheu J, Hawryluk EB, Guo D, London WB, Huang JT. Voriconazole phototoxicity in children: a retrospective review. J Am Acad Dermatol. 2015, 72:314-20. 10.1016\/j.jaad.2014.10.023","journal-title":"J Am Acad Dermatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1086\/598327","article-title":"Clinical relevance of the pharmacokinetic interactions of azole antifungal drugs with other coadministered agents","volume":"48","author":"Br\u00fcggemann RJ","year":"2009","unstructured":"Br\u00fcggemann RJ, Alffenaar JW, Blijlevens NM, Billaud EM, Kosterink JG, Verweij PE, Burger DM. Clinical relevance of the pharmacokinetic interactions of azole antifungal drugs with other coadministered agents. Clin Infect Dis. 2009, 48:1441-58. 10.1086\/598327","journal-title":"Clin Infect Dis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1099\/jmmcr.0.004135","article-title":"Peripheral eosinophilia and eosinophilic colitis during long-term azole therapy for pulmonary aspergillosis","volume":"1","author":"Grzegorczyk B","year":"2014","unstructured":"Grzegorczyk B, Murata Y. Peripheral eosinophilia and eosinophilic colitis during long-term azole therapy for pulmonary aspergillosis. JMM Case Rep. 2014, 1:e004135. 10.1099\/jmmcr.0.004135","journal-title":"JMM Case Rep"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1D404","article-title":"Fever and eosinophilia associated with voriconazole","volume":"38","author":"Vishnubhotla P","year":"2004","unstructured":"Vishnubhotla P, Ibrahim RB, Abidi MH, Chandrasekar PH. Fever and eosinophilia associated with voriconazole. Ann Pharmacother. 2004, 38:900-1. 10.1345\/aph.1D404","journal-title":"Ann Pharmacother"},{"key":"ref14","unstructured":"National Comprehensive Cancer Network. squamous cell carcinoma (version 2.2022). (2022). Accessed: 2022: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/squamous.pdf."},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-3498","article-title":"Update of the management of cutaneous squamous-cell carcinoma","volume":"100","author":"Maubec E","year":"2020","unstructured":"Maubec E. Update of the management of cutaneous squamous-cell carcinoma. Acta Derm Venereol. 2020, 100:adv00143. 10.2340\/00015555-3498","journal-title":"Acta Derm Venereol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(92)70144-5","article-title":"Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection","volume":"26","author":"Rowe DE","year":"1992","unstructured":"Rowe DE, Carroll RJ, Day CL. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection. J Am Acad Dermatol. 1992, 26:976-990. 10.1016\/0190-9622(92)70144-5","journal-title":"J Am Acad Dermatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/98485-voriconazole-induced-cutaneous-squamous-cell-carcinoma-in-an-immunocompetent-patient","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:35:48Z","timestamp":1707507348000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/98485-voriconazole-induced-cutaneous-squamous-cell-carcinoma-in-an-immunocompetent-patient"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,30]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.25508","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5,30]]}}}